You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

GSK Sells Irish Plant to Thermo Fisher in $102 Million Deal

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 680 Words

GALWAY, IRELAND--June 17, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) has agreed to sell its pharmaceutical manufacturing plant in Cork, Ireland, to U.S. company Thermo Fisher Scientific Incorporated (NYSE:TMO) (Waltham, Massachusetts) for 90 million euro ($102 million).

Within this article: Details plant sale, products produced, future plans and related GSK plant sell offs

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00